Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 1016-1018, 2005; 10.1373/clinchem.2004.045658
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauridsen, A. L.
Right arrow Articles by Nexo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauridsen, A. L.
Right arrow Articles by Nexo, E.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:1016-1018.)
© 2005 American Association for Clinical Chemistry, Inc.


Technical Briefs

Sensitive Automated ELISA for Measurement of Vitamin D-Binding Protein (Gc) in Human Urine

Anna Lis Lauridsen1,a, Michael Aarup2, Anna Lisa Christensen1, Bente Jespersen2, Kim Brixen3 and Ebba Nexo1

1 Department of Clinical Biochemistry, Norrebrogade, Aarhus University Hospital, Aarhus, Denmark; Departments of2 Nephrology and3 Endocrinology, Odense University Hospital, Odense, Denmark;

aaddress correspondence to this author at: Department of Clinical Biochemistry, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark; fax 45-8949-3060, e-mail all@dadlnet.dk

The first 300 words of the full text of this article appear below.

We report a sensitive automated ELISA for measurement of group-specific component (Gc; also known as Gc globulin and vitamin D-binding protein) that detects lower concentrations than any other published method. This new ELISA enables measurement of Gc in human urine.

Gc is a 50- to 58-kDa multifunctional plasma protein synthesized mainly by hepatocytes and usually present in plasma in concentrations between 4 and 6 µmol/L. The functions of Gc are diverse. Gc is an important player in the actin-scavenger system, which prevents the harmful consequences of actin in the blood stream during tissue injury. It binds actin monomers with high affinity, and Gc–actin complexes are rapidly cleared from the circulation (1). Gc also has functions in the immune system, acting as a co-chemotactic factor together with complement C5a (2) and, after deglycosylation, as a very potent macrophage-activating factor (Gc-MAF) also capable of activating osteoclasts (3)(4). The name "vitamin D-binding protein" is derived from its ability to bind and transport vitamin D metabolites. Usually, <0.1% of 25-hydroxyvitamin D (25OHD) and <1% of 1,25-dihydroxyvitamin D [1,25(OH)2D] circulate in their free forms (5). Gc is probably also important for the renal activation of 25OHD to 1,25(OH)2D. Mice lacking the multifunctional receptor megalin lose Gc–25OHD complexes in the urine and are deficient in 1,25(OH)2D (6). Thus, there is evidence that, generally, Gc and Gc–25OHD complexes are filtered in the glomerulus and reabsorbed by megalin-mediated endocytosis into the proximal tubular cells, where vitamin D activation takes place. This theory postulates that, under healthy conditions, only trace amounts of Gc should be excreted in the urine, whereas urinary loss of Gc is expected to increase with decreases in the capacity for reabsorption in the proximal tubules. To evaluate the fate of . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
D. Sviridov, B. Meilinger, S. K. Drake, G. T. Hoehn, and G. L. Hortin
Coelution of Other Proteins with Albumin during Size-Exclusion HPLC: Implications for Analysis of Urinary Albumin
Clin. Chem., March 1, 2006; 52(3): 389 - 397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.